ABC | Volume 110, Nº3, March 2018

Original Article Almeida Junior et al BNP, echo and clinical evaluation in heart failure Arq Bras Cardiol. 2018; 110(3):270-277 1. Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrilo JE, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med. 2002; 112(6):437-45. doi: https://doi.org/10.1016/ S0002-9343(02)01048-3. 2. Vinch CS, Aurigemma GP, Hill JC, Gaasch WH, Volturo G, Tighe DA, et al. Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol. 2003;91(9):1140-3. doi: https:// doi.org/10.1016/S0002-9149 (03)00170-X. 3. StevensonLW,Perloff JK.The limitedreliabilityofphysicalsigns forestimating hemodynamics in chronic heart failure. JAMA. 1989;261(6):884-8. doi: 10.1001/jama.1989.03420060100040. 4. Goldsmith SR, Brandimarte F, Gheorghiade M. Congestion as a therapeutic target in acute heart failure syndromes. Prog Cardiovasc Dis. 2010;52(5):383-92. doi: 10.1016/j.pcad.2009.11.005. 5. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al; BreathingNotProperlyMultinationalStudyInvestigators.Rapidmeasurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-7. doi: 10.1056/NEJMoa020233. 6. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43(4):635-41. doi: https://doi.org/10.1016/j.jacc.2003.09.044. 7. Rohde LE, Beck da Silva L, Goldraich L, Grazziotin TC, Palombini DV, Polanczyk CA, et al. Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol. 2004;20(7):697-702. PMID: 15197422. 8. Almeida Júnior GL, Esporcatte R, Rangel FO, Rocha RM, Gouvêa e Silva Gde M, Tura BR, et al. [Therapy of advanced heart failure adapted to hemodynamic objectives acquired by invasive hemodynamic monitoring]. Arq Bras Cardiol. 2005;85(4):247-53. doi: htpp://dx.doi.org/10.1590/ S0066-782X2005001700004. 9. Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J AmColl Cardiol. 2001;37(1):278-85. doi: https://doi.org/10.1016/S0735- 1097(00)01056-1. 10. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler-catheterization study. Circulation. 2000;102(15):1788-94. doi: https://doi.org/10.1161/01. CIR.102.15.1788. 11. Dini FL, Traversi E, Franchini M, Micheli G, Cobelli F, Pozzoli M. Contrast- enhanced Doppler hemodynamics for noninvasive assessment of patients with chronic heart failure and left ventricular systolic dysfunction. J Am Soc Echocardiogr. 2003;16(2):124-31. doi: 10.1067/mje.2003.8. 12. DaoQ, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J AmColl Cardiol. 2001;37(2):379-85. doi: https://doi.org/10.1016/S0735-1097 (00)01156-6. 13. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end- diastolic pressure in patients with symptomatic left ventricular dysfunction. AmHeart J. 1998;135(5 Pt 1):825-32. PMID: 9588412. 14. GoonewardenaSN,Blair JE,ManuchehryA,Brennan JM,KellerM,ReevesR, et al. Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients refered for right heart catheterization. J Card Fail. 2010;16(1):69-75. doi: 10.1016/j.cardfail.2009.08.004. 15. VillacortaH,Duarte A, DuarteNM,CarranoA,MesquitaET,DohmannHJ,et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol. 2002;79(6):564-8. doi: http://dx.doi.org/10.1590/S0066- 782X2002001500002. 16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. doi: https://doi.org/10.1016/j. echo.2005.10.005 17. Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J AmColl Cardiol. 1993;22(4):968- 74. https://doi.org/10.1016/0735-1097 (93)90405-P. 18. Vinayak AG, Levitt J, Gehlbach B, Pohlman AS, Hall JB, Kress JP. Usefulness of the External Jugular Vein Examination inDetecting Abnormal Central Venous Pressure in Critically Ill Patients. Arch Intern Med. 2006;166(19):2132-37. doi: 10.1001/archinte.166.19.2132. 19. Drazner MH, HamiltonMA, FonarowG, Creaser J, Flavell C, Stevenson LW. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18(11):1126-32. doi: https://doi.org/10.1016/S1053-2498 (99)00070-4. 20. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugularvenouspressureandathirdheartsound inpatientswithheart failure. N Engl J Med. 2001;345(8):574-81. doi: 10.1056/NEJMoa010641. 21. LeierCV,ChatterjeeK.Thephysicalexaminationinheartfailure-partI.Congest Heart Fail. 2007;13(1):41-7. doi: 10.1111/j.1527-5299.2007.06409.x. 22. Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail. 2001;7(6):297-308. doi: 10.1111/j.1527-5299.2001.01167.x. 23. Drazner MH, Prasad A, Ayers C, Markham DW, Hastings J, Bhella PS, et al. The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction. Circ Heart Fail. 2010;3(2):202-6. doi: 10.1161/CIRCHEARTFAILURE.108.876649. Erratum in: Circ Heart Fail. 2012;5(1):e17. 24. Leier CV. Examining the jugular vein is never in vain. Circ Heart Fail. 2010;3(2):175-7. doi: 10.1161/CIRCHEARTFAILURE.110.944116. 25. Collins SP, PeacockWF, Lindsell CJ, Clopton P, Diercks DB, Hiestand B, et al. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med. 2009;53(6):748-57. doi: 10.1016/j.annemergmed.2008.12.029. 26. Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, et al. Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA. 2005;293(18):2238-44. doi:10.1001/jama.293.18.2238. 27. Marcus G, Vessey J, Jordan MV, Huddleston M, McCkeown B, Gerber IL, et al. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch InternMed. 2006;166(6):617-22. doi: 10.1001/archinte.166.6.617. 28. Sauer J, Rabelo ER, Castro RA, Goldraich L, Rohde LE, Clausell N, et al. Nurse’s performance in classifying heart failure patients based on physical exam: comparisonwith cardiologist’s physical examand levels of n-terminal pro-B-type natriuretic peptide. J Clin Nurs. 2010;19(23-24):3381-9. doi: 10.1111/j.1365-2702.2010.03403.x. References 276